Infographic
Up to one third of all commercially available treatments act by binding to G protein coupled-receptors (GPCRs), making them a hot drug target. Agonist and antagonist therapies that target GPCRs are used to treat illness in almost every major organ system and are important in numerous therapeutic areas including oncology, cardiology, neurosciences, respiratory illnesses, metabolic disorders, and rare diseases.